This inventor holds 1 USPTO granted patent. Top assignee: Vyzkumny Ustav Pro Farmacii a Biochemii, Statni Podnik. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Eva Knezova: Innovator in Pharmaceutical Chemistry
Introduction
Eva Knezova is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic properties. Her work focuses on innovations that can improve health outcomes for patients.
Latest Patents
Eva Knezova holds a patent for a compound known as 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid, commonly referred to as DISALAZINE. This invention is recognized for its anti-arthritic and immunomodulating properties. The compound is synthesized through a reaction involving the diazonium salt of sulfadimidine and salicylic acid, followed by acetylation. This innovative approach offers potential benefits for individuals suffering from arthritis.
Career Highlights
Knezova is affiliated with the Research Institute for Pharmacy and Biochemistry, a state enterprise that focuses on advancing pharmaceutical research. Her work has been instrumental in developing new therapeutic agents that can enhance patient care. With a patent portfolio that includes one significant patent, she continues to contribute to the scientific community.
Collaborations
Eva Knezova has collaborated with esteemed colleagues such as Jiri Kejha and Bohumila Brunova. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Eva Knezova is a pioneering inventor whose work in pharmaceutical chemistry has the potential to make a lasting impact on healthcare. Her innovative contributions, particularly in the development of DISALAZINE, highlight her commitment to improving patient outcomes through scientific research.